NCT07544303 Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis)
| NCT ID | NCT07544303 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Artvin Coruh University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-09-09 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-09-09 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis. Hypotheses: 1. Quran recital reduces fatigue in MS patients. 2. Quran recital increases mental well-being in MS patients. The patients will be called by the researcher to ask whether they continue this practice. The control group will continue their routine treatment and care and no additional intervention will be applied. The final test measurements will be made by meeting with the patients in the hospital at the end of the 4th week.
Eligibility Criteria
Inclusion Criteria: 1. Having been diagnosed with Multiple Sclerosis at least 6 months ago 2. Being between the ages of 18-80 3. Agreeing to participate in the research 4. Not having any obstacles to wearing headphones 5. Not having any hearing problems Exclusion Criteria: 1. Those with major psychiatric disorders 2. Those with any obstacle to communication
Contact & Investigator
Sevgi Demir Cam, Asst. Prof
STUDY CHAIR
Artvin Çoruh University
Frequently Asked Questions
Who can join the NCT07544303 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07544303 currently recruiting?
Yes, NCT07544303 is actively recruiting participants. Contact the research team at sevgidemir91@hotmail.com for enrollment information.
Where is the NCT07544303 trial being conducted?
This trial is being conducted at Van, Turkey (Türkiye).
Who is sponsoring the NCT07544303 clinical trial?
NCT07544303 is sponsored by Artvin Coruh University. The principal investigator is Sevgi Demir Cam, Asst. Prof at Artvin Çoruh University. The trial plans to enroll 52 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.